Circulating Endothelial Cells as a Surrogate Marker of Antiangiogenic Activity in Patients Treated with Endostatin
Publication
, Conference
Force, JM; Heymach, JV; Kulke, MH; Fuchs, CS; Connors, S; Sidor, C; George, D; Eder, JP; Folkman, J; Soker, S
Duke Scholars
Conference Name
Proc Am Soc Clin Oncol
Citation
APA
Chicago
ICMJE
MLA
NLM
Force, J. M., Heymach, J. V., Kulke, M. H., Fuchs, C. S., Connors, S., Sidor, C., … Soker, S. (n.d.). Circulating Endothelial Cells as a Surrogate Marker of Antiangiogenic Activity in Patients Treated with Endostatin. Presented at the Proc Am Soc Clin Oncol.
Force, J. M., J. V. Heymach, M. H. Kulke, C. S. Fuchs, S. Connors, C. Sidor, D. George, J. P. Eder, J. Folkman, and S. Soker. “Circulating Endothelial Cells as a Surrogate Marker of Antiangiogenic Activity in Patients Treated with Endostatin,” n.d.
Force JM, Heymach JV, Kulke MH, Fuchs CS, Connors S, Sidor C, et al. Circulating Endothelial Cells as a Surrogate Marker of Antiangiogenic Activity in Patients Treated with Endostatin. In.
Force JM, Heymach JV, Kulke MH, Fuchs CS, Connors S, Sidor C, George D, Eder JP, Folkman J, Soker S. Circulating Endothelial Cells as a Surrogate Marker of Antiangiogenic Activity in Patients Treated with Endostatin.
Conference Name
Proc Am Soc Clin Oncol